Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS) (IBU-ALS-1201)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02238626
Recruitment Status : Completed
First Posted : September 12, 2014
Last Update Posted : February 15, 2021
Sponsor:
Collaborator:
Atrium Health
Information provided by (Responsible Party):
MediciNova

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2017
Actual Study Completion Date : December 2017
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 9, 2021